1 General principles
Carl Zeiss Meditec AG is a publicly listed stock corporation incorporated under German law and parent company of the Carl Zeiss Meditec Group (“Carl Zeiss Meditec”, “the Company”, “the Group”) with its registered office at Göschwitzer Straße 51-52, 07745 Jena (Germany) and entered in the commercial register of Jena District Court (HRB 205623).
The Group offers end-to-end solutions for the diagnosis and treatment of ophthalmic diseases, including implants and consumables. In microsurgery, the Group provides innovative visualization solutions. The Company’s end customers are physicians in various fields and hospitals worldwide.
These consolidated financial statements of Carl Zeiss Meditec AG, consisting of the consolidated income statement, consolidated statement of comprehensive income, consolidated statement of financial position, consolidated statement of changes in equity, consolidated statement of cash flows and notes to the consolidated financial statements, are based on the going concern assumption. They have been prepared in accordance with the International Financial Reporting Standards (“IFRSs”) and the interpretations of the International Financial Reporting Interpretations Committee, as adopted by the EU, and the additional requirements of German Commercial law in accordance with Section 315e (1) of the German Commercial Code (Handelsgesetzbuch, HGB). All pronouncements of the International Accounting Standards Board (IASB) whose adoption is mandatory have been considered.
In order to improve clarity and transparency, individual items have been combined in the consolidated statement of financial position and the consolidated income statement and broken down and explained separately in these notes.
The fiscal year of Carl Zeiss Meditec Group starts on 1 October and ends on 30 September.
The consolidated financial statements and group management report prepared as of 30 September 2025 were authorized for publication by the Management Board on 27 November 2025. The consolidated financial statements are published on the internet and in the business register.
Consolidated financial statements for the largest group of affiliated companies are prepared by Carl Zeiss AG (“ZEISS”, “Carl Zeiss Group”, the “parent company”, which is domiciled in 73447 Oberkochen, Germany (Carl-Zeiss-Straße 22). These are published on the internet and in the business register. Furthermore, the Company prepares its own consolidated financial statements according to International Financial Reporting Standards (“IFRS”), as applicable in the EU, thus preparing the consolidated financial statements for the smallest group of companies.